Culturally Adapted Manual-assisted Problem Solving Training Based Mobile Intervention

Launched by PAKISTAN INSTITUTE OF LIVING AND LEARNING · Aug 30, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new program designed to help people who are thinking about suicide. The program, called CAMI, uses a mobile app to provide support and problem-solving skills, and the researchers want to see how well it works compared to regular treatment. They hope to find out if this program is easy for people to use and whether it helps them feel better.

To be part of this study, you need to be between 18 and 64 years old and have thoughts of suicide. You’ll also need to be able to read and speak Urdu and have a smartphone that you can use. The trial is not looking for people who are currently in the hospital for mental health issues or who have certain medical conditions that could make it hard to participate. If you join the study, you can expect to use the app to help manage your feelings and thoughts, and you'll be guided by trained professionals. This trial is currently not recruiting participants yet, but it’s a chance to contribute to research that might help others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals (aged 18-64) screened and identified as having suicidal ideation
• • Able to give written informed consent
• • Living within the catchment areas of participating hospitals
• • Have a smart phone and able to operate it
• • Able to read and speak Urdu
• • Not requiring in-patient psychiatric treatment.
• Exclusion Criteria:
• • Presence of a diagnosed physical or intellectual disability as it can prevent individuals from engaging with the intervention. This will be assessed by the research team at screening stage. Any disabilities will be identified by a relevant clinician (e.g. Psychiatrist).
• • Temporary resident unlikely to be available for follow-up (b) participants with a diagnosis of DSM-IV mental disorder due to general medical condition or substance misuse, dementia, delirium, alcohol and drug dependence, schizophrenia, or bipolar disorder.